本页面由Tiger Trade Technology Pte. Ltd.提供服务

SAB Biotherapeutics, Inc.

2.83
-0.1500-5.03%
成交量:35.91万
成交额:103.19万
市值:2.57亿
市盈率:-1.82
高:3.00
开:2.99
低:2.80
收:2.98
52周最高:5.15
52周最低:2.10
股本:9,098.64万
流通股本:6,204.34万
量比:0.45
换手率:0.58%
股息:- -
股息率:- -
每股收益(TTM):-1.5562
每股收益(LYR):-0.7944
净资产收益率:-11.27%
总资产收益率:-33.46%
市净率:1.20
市盈率(LYR):-3.56

数据加载中...

2022/03/29

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/01

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/01/10

重要事件披露

8-K - Current report
2022/01/06

重要事件披露

8-K - Current report
2021/12/13

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/03

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/11/22

重要事件披露

8-K - Current report
2021/11/22

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/22

重要事件披露

8-K/A [Amend] - Current report
2021/11/19

重要事件披露

8-K - Current report
2021/11/02

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/01

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/01

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/10/28

重要事件披露

8-K - Current report
2021/10/22

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/10/21

重要事件披露

8-K - Current report
2021/10/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/13

重要事件披露

8-K - Current report